Greater China News
Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities
Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Series Pre-A financing
Verastem Oncology Enters Discovery and Development Collaboration with GenFleet Therapeutics to Advance New Programs Targeting RAS Pathway-Driven Cancers
Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company has entered into a discovery and development collaboration with GenFleet Therapeutics (“GenFleet”) to advance three oncology discovery programs targeting RAS pathway-driven cancers.
A China fund from Fidelity is beating the crowd. How it plans to keep doing it
Fidelity’s China Focus Fund is setting up for another year of outperformance, after ranking first last year among China equity funds tracked by Morningstar.
SoftBank-backed Neumora Therapeutics files for U.S. IPO
Neumora Therapeutics, a biopharmaceutical firm backed by biotech Amgen and Japan's SoftBank, on Friday filed for an initial public offering of its shares in New York.
Gina Raimondo hails ‘important beginning’ for US-China ties, wraps up trip at Boeing, Disneyland in Shanghai
US Commerce Secretary Gina Raimondo hailed 'an important beginning' for Beijing and Washington to manage tensions on Wednesday, while also calling on China to address market concerns for American firms.
China says the best way to ‘de-risk’ is to restore stability with the U.S.
China’s Ministry of Commerce said Thursday that restoring stability in U.S.-China trade relations is the best way to 'de-risk' — a twist to a term that’s become popular in international politics.
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results
Syngenta Group Reports H1 2023 Results
Syngenta Group today announced financial results for the first half and the second quarter of 2023.
Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
Adagene reported financial results for the six months ended June 30, 2023 and provided corporate updates.
Jacobio Pharma Announces 2023 Interim Results
Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, announced its 2023 interim results.
